Pathstone Holdings’s Bio-Techne TECH Stock Holding History

Pathstone Holdings’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Sell	29,812 -10,402	-26%	-$562K	0.01%	1081
2026 Q1	$2.1M	Buy	40,214 +286	+0.7%	+$17.2K	0.01%	996
2025 Q4	$2.35M	Sell	39,928 -4,748	-11%	-$288K	0.01%	934
2025 Q3	$2.49M	Buy	44,676 +14,304	+47%	+$766K	0.01%	901
2025 Q2	$1.56M	Sell	30,372 -8,000	-21%	-$402K	0.01%	1138
2025 Q1	$2.25M	Buy	38,372 +2,917	+8%	+$198K	0.01%	914
2024 Q4	$2.55M	Buy	35,455 +3,851	+12%	+$283K	0.01%	847
2024 Q3	$2.53M	Buy	31,604 +381	+1%	+$28.6K	0.01%	856
2024 Q2	$2.24M	Buy	31,223 +5,584	+22%	+$411K	0.01%	873
2024 Q1	$1.8M	Buy	25,639 +7,319	+40%	+$524K	0.01%	958
2023 Q4	$1.41M	Buy	+18,320	New	+$1.21M	0.01%	890

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pathstone Holdings's TECH Position: Q2 2026 in Review

Pathstone Holdings reduced its Bio-Techne (TECH) stake by 26% in Q2 2026, selling an estimated $562K and leaving 29,812 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #1081.

Pathstone Holdings first reported a position in TECH in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.55M in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Pathstone Holdings held 29,812 shares of Bio-Techne worth $2.11M as of Q2 2026.
Pathstone Holdings sold 10,402 Bio-Techne shares in Q2 2026, an estimated $562K.
Bio-Techne made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1081 holding.
Pathstone Holdings first reported a position in Bio-Techne in Q4 2023 and has held it in 11 quarters since.
Pathstone Holdings's Bio-Techne position peaked at $2.55M in Q4 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.